All In Biotech

Drug Trial Radar · NCT06021522

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Last checked: Nov 19, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Aug 16, 2023

Primary completion

Feb 2028

Study completion Feb 2028

Sponsor

Lead sponsor
Emalex Biosciences Inc.Industry
Sponsor type
Industry
First posted
Sep 1, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[\>=\] 6 and less than \[\<\] 12 years of age), adolescents (\>=12 and \<18 years of age), and adults (\>=18 years of age) with Tourette's Syndrome (TS).

Conditions

  • Tourette Syndrome

Interventions

  • EcopipamDrug

    Selective dopamine D1 and D5 receptor antagonist

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline up to Month 24

Locations

67 sites in 8 countries. Site status is shown where the registry gives one.

  • Harmonex, Inc.

    Dothan, Alabama

  • Arkansas Children's Hospital

    Little Rock, Arkansas

  • Advanced Research Center

    Anaheim, California

  • CenExel CIT-IE

    Bellflower, California

  • Cortica Site Network

    Glendale, California

  • Cortica Site Network - San Rafael

    San Rafael, California

  • Yale School of Medicine

    New Haven, Connecticut

  • Childrens National Hospital

    Washington D.C., District of Columbia

  • NW FL Clinical Research Group, LLC

    Gulf Breeze, Florida

  • Research in Miami Inc

    Hialeah, Florida

  • University of Miami Miller School of Medicine

    Miami, Florida

  • Florida International Research Center

    Miami, Florida

  • Medical Research Group of Central Florida

    Orange City, Florida

  • APG Research, LLC

    Orlando, Florida

  • University of South Florida

    St. Petersburg, Florida

  • Pediatric Epilepsy and Neurology Specialists

    Tampa, Florida

  • Rare Disease Research, LLC

    Atlanta, Georgia

  • Lurie Children Hospital of Chicago

    Chicago, Illinois

  • Rush University Medical Center

    Chicago, Illinois

  • Josephson-Wallack-Munshower Neurology

    Indianapolis, Indiana

  • University of Louisville Research Foundation Inc.

    Louisville, Kentucky

  • Kennedy Krieger Institute

    Baltimore, Maryland

  • Mass General Hospital

    Boston, Massachusetts

  • Boston Childrens Hospital

    Boston, Massachusetts

  • Umass Chan Medical School

    Worcester, Massachusetts

  • Michigan Clinical research Institute PC

    Ann Arbor, Michigan

  • Neurobahavioral Medicine Group

    Bloomfield Hills, Michigan

  • St. Louis Children's Hospital

    St Louis, Missouri

  • Alivation Research

    Lincoln, Nebraska

  • University of Rochester

    Rochester, New York

  • OnSite Clinical Solutions LLC

    Charlotte, North Carolina

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • National Childrens Hospital - The Ohio State University

    Columbus, Ohio

  • North Star Medical Research, LLC

    Middleburg Heights, Ohio

  • Providence Brain and Spine Institute

    Portland, Oregon

  • Coastal Pediatric Research

    Charleston, South Carolina

  • Access Clinical Trials, Inc.

    Nashville, Tennessee

  • Access Clinical Trials, Inc.

    Nashville, Tennessee

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • UT Southwestern

    Dallas, Texas

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.